DEC 23, 2018 11:22 PM PST

Type 2 Diabetes Drug May Treat Heart Failure Syndrome

WRITTEN BY: Nouran Amin

A drug used in the treatment of Type 2 Diabetes, by the name of Metformin, may soon be used to treat heart failure syndrome with preserved ejection fraction (HFpEF), a diagnosis that by year 2020 is predicted to affect 8% of people 65 or older. The study was carried out by the University of Arizona and shows that metformin was observed to relax a key protein present in the cardiac muscle known as titin—a protein that holds a significant role in allowing the heart to fill with blood prior to pumping it around the body.

Learn more about the anatomy of the human heart:

The condition of HFpEF involves the stiffness of the left ventricle which reduces the blood supply to the body despite proper contraction. HFpEF occurs in about half of all heart failure patients and is more common in women with risk factors including old age, hypertension, and obesity. As of now, no drugs are currently available for the treatment of HFpEF.

However, results of the study published in the Journal of General Physiology, concludes that metformin may soon be an effective therapeutic for HFpEF because it increases the left ventricular dilation and reduces the rate of heart failure in diabetic patients. The observations were seen in model mice with HFpEF-like symptoms that were given the drug. Metformin acts on titin to ultimately relax the left ventricle. Naturally, titin allows the cardiac muscle to recoil after stretching. Specifically, the drug adds phosphate groups on the titin causing it to become more complaint and allowing the heart muscle as whole to do the same.

Metformin is currently used for the management of Type 2 Diabetes. Now, research is suggesting it is a possible therapeutic for heart failure syndrome with preserved ejection fraction (HFpEF).

Credit: DiabetesSelfManagement.com

"We therefore conclude that metformin is a potential therapy for patients with HFpEF," says Henk L. Granzier at the Sarver Heart Center of the University of Arizona. "Because the drug is already approved and well tolerated in humans, using it to target titin stiffness presents a unique opportunity for immediate translation to the clinic."

Source: Journal of General Physiology, Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 13, 2019
Health & Medicine
NOV 13, 2019
A Skin Patch Might be the Most Effective Melanoma Treatment
Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medicati...
NOV 13, 2019
Drug Discovery & Development
NOV 13, 2019
Re-Evaluating a Popular Heart Failure Drug
A recent study found that the popular heart drug--sacubitril/valsartan—holds positive effects on the structure and function of the failing heart. Spe...
NOV 13, 2019
Genetics & Genomics
NOV 13, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
NOV 13, 2019
Drug Discovery & Development
NOV 13, 2019
Transplanted Brain Stem Cells Survive Without Anti-Rejection Drugs
Researchers at Johns Hopkins Medicine have successfully transplanted brain cells without the need of immune-suppressing drugs. Findings of the study were p...
NOV 13, 2019
Genetics & Genomics
NOV 13, 2019
Breast Cancer Drug Increases Survival for Prostate Cancer Patients
A breast cancer drug is better at treating advanced prostate cancer in some men than current therapies, a clinical trial shows....
NOV 13, 2019
Drug Discovery & Development
NOV 13, 2019
Tailor-made Drug for Girl with Rare Genetic Disease
Researchers have used personalized medicine to develop a tailor-made genetic treatment for a girl diagnosed with a rare genetic disease known as Batten dis...
Loading Comments...